Insider Sale: EVP & Chief Financial Officer of $RIGL Sells 1,734 Shares

Quiver QuantitativeFeb 6 20:31 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaJan 23 07:05 ET

Rigel Enrolls First Patient In Phase 1 Study Evaluating Fostamatinib In Sickle Cell Disease

BenzingaJan 22 08:12 ET

Rigel's Fostamatinib Being Studied by National Institute of Health in Patients With Sickle Cell Disease

PR NewswireJan 22 08:05 ET

Improved Revenues Required Before Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Stock's 28% Jump Looks Justified

Simply Wall StJan 22 05:49 ET

Kissei Pharmaceutical's Partner JW Pharmaceutical Gains Approval for Tavalisse in South Korea

MT NewswiresJan 21 20:16 ET